BIOXYTRAN, INC
For the period ended Dec 31, 2024. Filed Apr 3, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 3, 2025
BIXTStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
FINANCIAL STATEMENTS AND FOOTNOTES
BIOXYTRAN, INC.
FINANCIAL STATEMENTS
TABLE OF CONTENTS
| Page | |
| Report of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Financial Statements | |
| Consolidated Balance Sheets for the years ended December 31, 2024 and December 31, 2023 | F-3 |
| Consolidated Statements of Operations for the years ended December 31, 2024 and December 31, 2023 | F-4 |
| Consolidated Statements of Changes in Stockholders’ Deficit for the years ended December 31, 2024 and December 31, 2023 | F-5 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2024 and December 31, 2023 | F-6 |
| Notes to Consolidated Financial Statements for the years ended December 31, 2024 and December 31, 2023 | F-7 – F-24 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.